Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 01, 2020
Source ID
10.1016/j.cell.2020.10.037

Entities

People

  • Alan Aderem
  • Alexander M. Xu
  • Alissa Rothchild
  • Andrew T Magis
  • Brett Smith
  • Chengzhen Dai
  • Christopher Dale
  • Christopher Lausted
  • Clifford C Rostomily
  • D. Shane O’mahony
  • Dan Yuan
  • Daniel Chen
  • Guangrong Qin
  • Heather A. Algren
  • James R. Heath
  • Jason D Goldman
  • Jeffrey A. Bluestone
  • Jennifer J. Hadlock
  • Jing Zhou
  • Jingyi Xie
  • John E. Heath
  • John Earls
  • Jongchan Choi
  • Julie A. Wallick
  • Kai Wang
  • Kelsey Scherler
  • Kim Murray
  • Lee Rowen
  • Leroy Hood
  • Lesley Jones
  • Lewis L. Lanier
  • Li Jing
  • Mark M. Davis
  • Michael A Zager
  • Naeha Subramanian
  • Nathan D Price
  • Pamela Troisch
  • Philip D. Greenberg
  • Priyanka Baloni
  • Rachel Liu
  • Raphael Gottardo
  • Rick Edmark
  • Rongyu Zhang
  • Ryan Roper
  • Sarah Li
  • Sean Mackay
  • Sergey A Kornilov
  • Shen Dong
  • Sui Huang
  • Sunga Hong
  • Valentin Voillet
  • Venkata R. Duvvuri
  • Wei Wei
  • Yapeng Su
  • Yong Zhou

Organizations

  • Biomedical Advanced Research and Development Authority
  • Gates Foundation
  • National Center for Advancing Translational Sciences
  • National Institutes of Health
  • United States Department of Defense